News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Will Trump Make Biotech ETFs Great Again?



11/29/2016 7:14:39 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Biotechnology exchange traded funds have rebounded after the presidential election and could find further strength under a Donald Trump administration.

On the upcoming webcast, Will Trump Make Biotechnology Great Again?, Andrew McDonald, CEO of LifeSci Advisors and Co-Portfolio Manager of the BioShares funds, and Paul Yook, Founder of LifeSci Index Partners, and Co-Portfolio Manager of the BioShares funds, will try to outline biotechnology’s life under President-elect Trump and look to potential opportunities in cutting-edge drug producers.

For instance, the BioShares Biotechnology Clinical Trials Fund (NasdaqGM: BBC) tracks potential up-and-coming biotechnology companies that are in the clinical trials stage, providing investors with the opportunity to gain exposure to a high-growth segment of the global economy.

Read at News Release


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES